BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22909823)

  • 1. G1691A factor V and G20210A FII mutations, acute ischemic stroke of unknown cause, and patent foramen ovale.
    Favaretto E; Sartori M; Conti E; Legnani C; Palareti G
    Thromb Res; 2012 Nov; 130(5):720-4. PubMed ID: 22909823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do common prothrombotic mutations influence the risk of cerebral ischaemia in patients with patent foramen ovale? Systematic review and meta-analysis.
    Pezzini A; Grassi M; Zotto ED; Giossi A; Volonghi I; Costa P; Grau A; Magoni M; Padovani A; Lichy C
    Thromb Haemost; 2009 May; 101(5):813-7. PubMed ID: 19404532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale.
    Pezzini A; Del Zotto E; Magoni M; Costa A; Archetti S; Grassi M; Akkawi NM; Albertini A; Assanelli D; Vignolo LA; Padovani A
    Stroke; 2003 Jan; 34(1):28-33. PubMed ID: 12511746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution.
    Mazoyer E; Ripoll L; Gueguen R; Tiret L; Collet JP; dit Sollier CB; Roussi J; Drouet L;
    Blood Coagul Fibrinolysis; 2009 Oct; 20(7):503-10. PubMed ID: 19730248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombotic mutations as risk factors for cryptogenic ischemic cerebrovascular events in young subjects with patent foramen ovale.
    Botto N; Spadoni I; Giusti S; Ait-Ali L; Sicari R; Andreassi MG
    Stroke; 2007 Jul; 38(7):2070-3. PubMed ID: 17525392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale.
    Karttunen V; Hiltunen L; Rasi V; Vahtera E; Hillbom M
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):261-8. PubMed ID: 12695749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor V Leiden G1691A and factor II G20210A point mutations and pregnancy in North-West of Iran.
    Bagheri M; Rad IA; Nanbakhsh F
    Arch Gynecol Obstet; 2011 Nov; 284(5):1311-5. PubMed ID: 21773779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey.
    Altintas A; Pasa S; Akdeniz N; Cil T; Yurt M; Ayyildiz O; Batun S; Isi H
    Ann Hematol; 2007 Oct; 86(10):727-31. PubMed ID: 17572893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.
    Finan RR; Tamim H; Ameen G; Sharida HE; Rashid M; Almawi WY
    Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prothrombin G20210A mutation, but not factor V Leiden, is a risk factor in patients with persistent foramen ovale and otherwise unexplained cerebral ischemia.
    Lichy C; Reuner KH; Buggle F; Litfin F; Rickmann H; Kunze A; Brandt T; Grau A
    Cerebrovasc Dis; 2003; 16(1):83-7. PubMed ID: 12766367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Patent foramen ovale: "les liaisons dangereuses" between anatomy and genetics].
    Botto N; Ait-Ali L; Sicari R; Spadoni I; Andreassi MG
    Recenti Prog Med; 2009; 100(7-8):356-60. PubMed ID: 19725476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)].
    Kvasnicka J; Hájková J; Bobcíková P; Kvasnicka T; Dusková D; Poletínová S; Kieferová V
    Cas Lek Cesk; 2012; 151(2):76-82. PubMed ID: 22515013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years.
    Lalouschek W; Schillinger M; Hsieh K; Endler G; Tentschert S; Lang W; Cheng S; Mannhalter C
    Stroke; 2005 Jul; 36(7):1405-9. PubMed ID: 15947254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic stroke and patent foramen ovale: risk factors and genetic profile.
    Lantz M; Sjöstrand C; Kostulas K
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):841-5. PubMed ID: 22784820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of polymorphisms Leiden Factor V G1691A and prothrombin G20210A as risk factors for acute myocardial infarction.
    Forte GI; Vaccarino L; Palmeri M; Branzi A; Caldarera CM; Scola L; Caruso C; Licastro F; Lio D
    Biogerontology; 2011 Oct; 12(5):485-90. PubMed ID: 21918818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
    Mueller T; Marschon R; Dieplinger B; Haidinger D; Gegenhuber A; Poelz W; Webersinke G; Haltmayer M
    J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
    Yasa MH; Bolaman Z; Yukselen V; Kadikoylu G; Karaoglul AO; Batun S
    Hepatogastroenterology; 2007; 54(77):1438-42. PubMed ID: 17708272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombophilic polymorphisms - factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T - in Tunisian patients with cerebral venous thrombosis.
    Ben Salem-Berrabah O; Fekih-Mrissa N; N'siri B; Ben Hamida A; Benammar-Elgaaied A; Gritli N; Mrissa R
    J Clin Neurosci; 2012 Sep; 19(9):1326-7. PubMed ID: 22721898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between adverse pregnancy outcomes and maternal factor V G1691A (Leiden) and prothrombin G20210A genotypes in women with a history of recurrent idiopathic miscarriages.
    Mahjoub T; Mtiraoui N; Tamim H; Hizem S; Finan RR; Nsiri B; Almawi WY
    Am J Hematol; 2005 Sep; 80(1):12-9. PubMed ID: 16138341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.